Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

Cancer Immunology, Immunotherapy

Volumn 57, Issue 11, 2008, Pages 1665-1673

  Stoitzner, Patrizia ^a,b   Green, Laura K ^a   Jung, Jae Y ^a   Price, Kylie M ^a   Atarea, Haley ^a   Kivell, Bronwyn ^c   Ronchese, Franca ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Dendritic cells; Melanoma; Tumor immunity

Indexed keywords

OVALBUMIN; PEPTIDE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; LEUKOCYTE; LYMPH NODE; MACROPHAGE; MELANOMA CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; LEUKOCYTES; LYMPH NODES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 50649090044     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0487-4     Document Type: Article

References (26)

1. MJ Barnden J Allison WR Heath FR Carbone 1998 Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements Immunol Cell Biol 76 34 40
2. D Bell P Chomarat D Broyles G Netto GM Harb S Lebecque J Valladeau J Davoust KA Palucka J Banchereau 1999 In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas J Exp Med 190 1417 1426
3. K Bennaceur I Popa J Portoukalian O Berthier-Vergnes J Peguet-Navarro 2006 Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis Int Immunol 18 879 886
4. O Berthier-Vergnes M Gaucherand J Peguet-Navarro J Plouet JF Pageaux D Schmitt MJ Staquet 2001 Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells Br J Cancer 85 1944 1951
5. C Chiodoni P Paglia A Stoppacciaro M Rodolfo M Parenza MP Colombo 1999 Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response J Exp Med 190 125 133
6. TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram M Evdemon-Hogan JR Conejo-Garcia L Zhang M Burow Y Zhu S Wei I Kryczek B Daniel A Gordon L Myers A Lackner ML Disis KL Knutson L Chen W Zou 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942 949
7. KA Hogquist SC Jameson WR Heath JL Howard MJ Bevan FR Carbone 1994 T cell receptor antagonist peptides induce positive selection Cell 76 17 27
8. AY Huang P Golumbek M Ahmadzadeh E Jaffee D Pardoll H Levitsky 1994 Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens Science 264 961 965
9. T Ishida T Oyama DP Carbone DI Gabrilovich 1998 Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors J Immunol 161 4842 51
10. S Kusmartsev DI Gabrilovich 2002 Immature myeloid cells and cancer-associated immune suppression Cancer Immunol Immunother 51 293 298
11. M Li GM Davey RM Sutherland C Kurts AM Lew C Hirst FR Carbone WR Heath 2001 Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo J Immunol 166 6099 6103
12. AA Lugade JP Moran SA Gerber RC Rose JG Frelinger EM Lord 2005 Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor J Immunol 174 7516 7523
13. AB Lyons 2000 Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution J Immunol Methods 243 147 154
14. AL Marzo BF Kinnear RA Lake JJ Frelinger EJ Collins BW Robinson B Scott 2000 Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity J Immunol 165 6047 6055
15. AL Marzo RA Lake D Lo L Sherman A McWilliam D Nelson BW Robinson B Scott 1999 Tumor antigens are constitutively presented in the draining lymph nodes J Immunol 162 5838 5845
16. AD McLellan M Kapp A Eggert C Linden U Bommhardt EB Brocker U Kammerer E Kampgen 2002 Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression Blood 99 2084 2093
17. M Movassagh A Spatz J Davoust S Lebecque P Romero M Pittet D Rimoldi D Lienard O Gugerli L Ferradini C Robert MF Avril L Zitvogel E Angevin 2004 Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma Cancer Res 64 2192 2198
18. S Nagaraj K Gupta V Pisarev L Kinarsky S Sherman L Kang DL Herber J Schneck DI Gabrilovich 2007 Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer Nat Med 13 828 835
19. F Ossendorp RE Toes R Offringa SH van der Burg CJ Melief 2000 Importance of CD4(+) T helper cell responses in tumor immunity Immunol Lett 74 75 79
20. A Pinzon-Charry T Maxwell JA Lopez 2005 Dendritic cell dysfunction in cancer: a mechanism for immunosuppression Immunol Cell Biol 83 451 461
21. O Preynat-Seauve E Contassot P Schuler V Piguet LE French B Huard 2007 Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process Cancer Res 67 5009 5016
22. O Preynat-Seauve P Schuler E Contassot F Beermann B Huard LE French 2006 Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection J Immunol 176 61 67
23. BW Robinson RA Lake DJ Nelson BA Scott AL Marzo 1999 Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation Immunol Cell Biol 77 552 558
24. FJ Tefany RS Barnetson GM Halliday SW McCarthy WH McCarthy 1991 Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma J Invest Dermatol 97 197 202
25. GJ van Mierlo ZF Boonman HM Dumortier AT den Boer MF Fransen J Nouta EI van der Voort R Offringa RE Toes CJ Melief 2004 Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication J Immunol 173 6753 6759
26. AP Vicari C Chiodoni C Vaure S Ait-Yahia C Dercamp F Matsos O Reynard C Taverne P Merle MP Colombo A O'Garra G Trinchieri C Caux 2002 Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody J Exp Med 196 541 549